(CIDRAP News) Pushed by this year's influenza vaccine crisis, Congress recently approved $99 million to improve the nation's capacity to produce influenza vaccine, according to the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) Federal health officials painted a rosy picture of the influenza vaccine supply today, saying most states have enough vaccine and the nation as a whole seems to have enough to meet the demand from groups who need the shots the most.
(CIDRAP News) When doctors in Maryland needed influenza vaccine for high-risk patients recently, they didn't send a request to a private distributor. They turned to Minnesota instead.
As part of efforts to improve the nation's long-term supply of influenza vaccine, the federal government is launching a clinical trial to help get a German-made vaccine licensed for regular use in the United States.
(CIDRAP News) If states have extra influenza vaccine left in the private sector after the demand from high-priority groups has been met, people in lower-priority groups should be allowed to get flu shots, federal health officials said yesterday.
(CIDRAP News) Freelance vaccinations and offers of bootleg vaccine are two unusual side effects of the US influenza vaccine shortage.
(CIDRAP News) The federal government is buying 1.2 million doses of flu vaccine made in Germany to augment the strained US supply, the Department of Health and Human Services (HHS) announced today.
(CIDRAP News) Clinical trials of a vaccine designed to keep the H5N1 avian influenza virus from sparking a human flu pandemic will begin early in 2005, the head of the National Institute of Allergy and Infectious Diseases (NIAID) said this week.
(CIDRAP News) – The current shortage of influenza vaccine has generated new support for proposed federal legislation introduced last January that would make the production of flu vaccine more financially attractive, according to sponsors of the bill.
(CIDRAP News) In an effort to spread the impact of the influenza vaccine shortage fairly, federal health officials today announced a plan to share most of the approximately 11 million remaining doses of injectable vaccine among states on the basis of need.